Balabanova, Yanina
Farahmand, Bahman
Stattin, Pär
Garmo, Hans
Brobert, Gunnar
Article History
Received: 10 June 2021
Accepted: 21 January 2022
First Online: 2 February 2022
Declarations
:
: The study was carried out in accordance with the Helsinki Declaration. There was no requirement for informed consent by the Research Ethics Authority, Uppsala—the ethics committee that approved the study protocol (Dnr 2019-01319). The Research Ethics Authority Uppsala approved the use of the opt-out informed consent in NPCR for which there is no collection of signed consent.
: Not applicable.
: YL is an employee of Bayer AG. BF and GB are employees of Bayer AB. PS declares that Region Uppsala has, on behalf of NPCR, made agreements on quarterly reports from Patient-overview Prostate Cancer (part of NPCR) with Astellas, Janssen, and Bayer, as well as research projects with Astellas, Bayer, and Janssen. HG declares no conflicts of interest.